[Interferon therapy in chronic active viral hepatitis].
The authors give a short review of the recent data about the types of interferons and their biological activity. The role of interferons in the therapy of B, C and D chronic viral hepatitis is discussed. Interferon treatment means a substantial progress in the therapy of chronic viral hepatitis, however it represents a final recovery from chronic B or C hepatitis only in 25-40 percent or 40-45 percent of the cases, respectively. The authors refer to the combination therapy which seems to be promising in the future.
Lengyel
G
G
II. Belklinika, Semmelweis Orvostudományi Egyetem, Budapest.
Fehér
J
J
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy* / Q000382:microbiology; D006526:Hepatitis C / Q000188:drug therapy* / Q000382:microbiology; D003699:Hepatitis D / Q000188:drug therapy* / Q000382:microbiology; D006521:Hepatitis, Chronic / Q000188:drug therapy* / Q000382:microbiology; D006525:Hepatitis, Viral, Human / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use*; D008297:Male
D000276:Adjuvants, Immunologic; D016898:Interferon-alpha; D007372:Interferons